Skip to main content
About Us

A Global Network for Head and Neck Cancer Research

Head and neck cancers represent a complex group of diseases with significant geographical variation in incidence, risk factors, biology, and treatment outcomes. As treatment becomes increasingly personalised, the population of patients eligible for specific clinical trials continues to shrink.

This makes international collaboration essential.

HNCIG was created to address this challenge by connecting cooperative research groups and enabling large-scale international clinical studies.

Through its global network, HNCIG enables:

  • multinational clinical trials
  • collaborative translational research
  • harmonisation of research methodologies
  • data sharing and global research infrastructure

By coordinating efforts across continents, HNCIG increases the efficiency, diversity, and impact of clinical research in head and neck oncology.

 

Mission & Vision Our Committees

 

The Board

Hisham Mehanna
Hisham Mehanna

Chair

UK

Andreas Dietz
Andreas Dietz

Treasurer. German HN Study Group, IATG KH

Germany

Amanda Psyrri
Amanda Psyrri

Secretary. Hellenic Cooperative Oncology Group, HeCOG

Greece

Lachlan McDowell
Lachlan McDowell

Trans Tasman Radiation Oncology Group, TROG

Australia

Luiz Kowalski
Luiz Kowalski

Latin American Cooperative Oncology Group, LACOG

Brazil

Scott Bratman
Scott Bratman

Canadian Cancer Trials Group,CCTG

Canada

Chaosu Hu
Chaosu Hu

Fudan University

China

Kristine Bjoerndal
Kristine Bjoerndal

Danish Head and Neck Cancer Group, DAHANCA

Denmark

Silke Tribius
Silke Tribius

European Organization of Research and Treatment of Cancer, EORTC

EU

Yungan Tao
Yungan Tao

Head and Neck Oncology and Radiotherapy Group, GORTEC

France

Dora Kwong
Dora Kwong

Hong Kong Nasopharyngeal Carcinoma Study Group, HKNPCSG

Hong Kong

Sarbani Laskar
Sarbani Laskar

Tata Memorial Centre, TMC

India

Sinead Brennan
Sinead Brennan

Cancer Trials Ireland, CTI

Ireland

Lisa Licitra
Lisa Licitra

Italian H&N Group, GONO

Italy

Naomi Kiyota
Naomi Kiyota

Head and Neck Cancer Study Group of the Japan Clinical Oncology Group, JCOG-HNCSG

Japan

Remco de Bree
Remco de Bree

Nederlandse WerkGroep Hoofd-Hals Tumoren, NWHHT

Netherlands

Melvin Chua
Melvin Chua

National Cancer Centre, NCC

Singapore

Pei-Jen Alex
Pei-Jen Alex

Taiwan Collaborative Oncology Group, TCOG

Taiwan

Gema Bruixola
Gema Bruixola

Spanish Foundation for Treatment of Head and Neck Tumors, FETTCC

Spain

Martin Forster
Martin Forster

National Cancer Research Institute, NCRI

UK

Sue Yom
Sue Yom

NRG Oncology

USA

Rathan Subramaniam
Rathan Subramaniam

Eastern Cooperative Oncology Group, ECOG

USA

Ana Gomes
Ana Gomes

Portuguese Head & Neck Cancer Study Group, GECCP

Portugal

Petr Szturz
Petr Szturz

Swiss Group for Clinical Cancer Research, SAKK

Switzerland

Jan Vermorken
Jan Vermorken

Observer

Danny Rischin
Danny Rischin

Observer

Our Purpose

"Uniting the global head and neck cancer community to accelerate research, advance innovation, and improve outcomes for patients worldwide."